MedDataX Logo

Cardiac Functions in Living Donor Liver Transplant Recipients. An Echocardiographic Study.

NCT ID: NCT01840514

Last Updated: 2013-10-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-12-31

Study Completion Date

2015-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The stress of orthotopic living donor liver transplantation in patients with cirrhosis could induce worsening of an already recorded myocardial dysfunction or may be associated with a new myocardial dysfunction in patients previously having normal myocardial functions, therefore this study will be designed for intra-operative detection of new onset ventricular dysfunction or worsening of already diagnosed ventricular dysfunction in living donor liver transplant recipient and the possible contribution of several hemodynamic and oxygenation parameters in the generation of any cardiovascular function impairment will be also investigated and to determine the impact of ventricular dysfunction on early (7 PO days) graft function, 28 days survival and patient outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Liver Transplant

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

recipient

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all adult recipient

Exclusion Criteria

* massive blood transfusion
* grade III esophageal varices
Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mansoura University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Amr Mohamed Yassen

professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

amr yassen, MD

Role: PRINCIPAL_INVESTIGATOR

Liver transplant program, mansoura faculty of medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Liver transplantation program - Gastroenterology surgical center

Al Mansurah, Dakahlia Governorate, Egypt

Site Status RECRUITING

Liver transplantation project - Gastroenterology surgical center - Mansoura university

Al Mansurah, Dakahlia Governorate, Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

amr M yassen, MD

Role: CONTACT

Phone: +201001497044

Email: [email protected]

Waleed R Elsarraf, MD

Role: CONTACT

Phone: +201222322727

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Amr M Yassen, MD

Role: primary

Waleed R alsarraf, MD

Role: backup

Amr M Yassen, MD

Role: primary

Waleed R Elsarraf, MD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1982

Identifier Type: -

Identifier Source: org_study_id